A new study found a blood test could identify some women at higher risk of recurrence of early triple negative breast cancer months before it became detectable through standard follow-up. But there’s ...

The Lancet Oncology Commission on accelerating equitable access to cancer genomics and precision oncology provides an important framework defining indicators that health systems can and should measure ...

A panel of outside advisers will vote this week on whether to recommend that the Food and Drug Administration grant the first ...

Atherosclerotic cardiovascular disease is the primary driver of premature death in global populations in recent decades.

While heart transplantation (HT) is the optimal therapy for end-stage heart failure patients, longevity of HT recipients ...

Being the brilliant kid in class can make everyone think they know where your future is headed. We found some wild stories ...

Results from a major study on daraxonrasib for pancreatic cancer that showed a nearly doubling of median survival rates earned a standing ovation from doctors at the 2026 American Society of Clinical ...

About 1 in 8 men will learn that they have prostate cancer at some point in their lifetime. And while most who are diagnosed will survive, prostate cancer can be serious. It’s the second-leading cause ...

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers ...

A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to standard ...